Nocturna Therapeutics

About:

Biotech company developing novel circular RNA-based therapies to treat currently incurable diseases

Website: http://www.nocturnatx.com

Description:

NoctuRNA Therapeutics is a biotech dedicated to developing novel and patented circular RNA-based therapies aimed at treating incurable diseases. Our focus spans infectious diseases such as Covid, Dengue, West Nile Virus and Hepatitis, as well as neuromuscular and neurodegenerative diseases that share common therapeutic targets. We are committed to pioneering innovative approaches to address significant unmet medical needs.

Total Funding Amount:

663000 EUR

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2022-12-16

Contact Email:

mcorredor(AT)nocturnatx.com

Founders:

Amadis Pages, Ivan Dotu, Juana Díez, Marc Talló, Miriam Corredor

Number of Employees:

1-10

Last Funding Date:

2023-01-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai